© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Quinine’s tale starts with the ancient forests of South America. Indigenous people drew bitter extracts from the bark of the cinchona tree to fight fevers and chills, which centuries later scientists would diagnose as malaria. Spanish colonizers caught on and brought this bark to Europe, where demand shot up quickly. Chemistry moved swiftly through the 19th century; French researchers Pelletier and Caventou managed to extract quinine in a more stable, crystalline form around 1820. Over decades, the sulfate salt came into play because its stability and solubility offered tangible advantages for preparation and storage in pharmacy settings. The dihydrate variant—the one with two water molecules attached to each quinine sulfate molecule—soon became the pharmaceutical standard, prized for predictable properties and consistent dosing. As the world grappled with malaria across continents, governments and private companies funneled resources into cinchona plantations in Asia and Africa, keeping supplies secure through colonial expansions and wars. This long journey, forged through hardship and discovery, shaped not just medicine but global trade and geopolitics.
Quinine sulfate dihydrate holds a core spot among antimalarial drugs, though tradition gives it a broader application in treating nocturnal leg cramps and as a bitter agent in soft drinks and tonics. Prevailing in tablet, capsule, and injectable forms, its role as a prescription drug depends on clear clinical justification. The dihydrate layer locks a certain percentage of moisture inside, controlling release and absorption rates. Companies that produce and distribute quinine must coordinate tightly with regulatory agencies, ensuring lots remain pure and potent. Unscrupulous sourcing or loose manufacturing standards mean lives on the line, not just statistics on a report.
Quinine sulfate dihydrate looks like a white, odorless, and almost tasteless powder, a bit granular to the touch. Water solubility sits moderate: warmer water dissolves it best, but alcohol also works decently for lab prep. The formula C20H24N2O2•H2SO4•2H2O, with a molar mass hovering near 782 g/mol, underlines just how much bulk comes from the extra water molecules. It melts at relatively low temperatures for such a large molecule, which makes sense given the organic structure. A cup in a well-equipped lab will show fluorescence under UV light—a neat trick that hints at its unique structure. When storing, light and air degrade the substance, so opaque, tightly sealed containers work best. Nobody wants a spoiled batch, especially in tropical clinics where logistics get tricky.
Clear rules set by bodies like the USP and EP spell out how quinine sulfate dihydrate should arrive in the market: percent purity, levels of heavy metals, allowable microbial contamination, and moisture content all sit under strict scrutiny. Tablet manufacturers must label active content by mass—ideally reporting both the base and the salt form—to cut confusion. Warnings flag risks for pregnant patients, anyone with heart rhythm troubles, or those on conflicting drugs. Shipping labels must signal special handling: keep cool, shield from light, and treat as a substance with substantial toxicity under the wrong circumstances. Miss a step, and public confidence in medicine takes a direct hit, as recalled batches in the past have shown.
Crafting pure quinine sulfate dihydrate starts with the dry, mature bark of cultivated cinchona trees, harvested and dried as freshly as possible to capture high alkaloid content. Extraction with acidified water or alcohol pulls quinine and its sister compounds out. Then comes a careful, stepwise purification: shaking with solvents, passing through filters, sometimes even treating with activated carbon to remove color and impurities. Sulfuric acid is added to precipitate the sulfate, and then careful crystallization kicks in—temperature and pH matter a lot here, since impurities or too-rapid cooling lead to clumped, impure crystals. After harvest, controlled drying under low heat captures just two water molecules per salt particle. Skimp on this, and you either lose structure or take on too much moisture, ruining shelf stability. Factories with scale process hundreds of kilograms with precise monitoring, but even small-batch chemists need to respect each variable or face batch rejection.
The quinoline skeleton at the heart of quinine guides most chemical tweaks. Exposure to strong acid or base can hydrolyze certain pieces, chopping larger quinine into fragments with no antimalarial kick. Oxidizing agents can notch the dihydroxyl portion, sometimes opening possibilities for new derivatives, but most changes dampen its pharmacological punch. Sulfate addition, the standard route, improves solubility. Chiral modification—changing its stereochemistry—either robs its pharmacology or creates totally different biological activities; for instance, synthesizing pseudo-quinine has led to expensive failures in drug trials. Science sometimes tags the molecule with isotopes or fluorescent groups, helpful in research but rarely in applied medicine. Unlike some newer drugs, quinine doesn’t lend itself easily to major functional tweaking without breaking its storybook effectiveness.
People in the business know quinine sulfate dihydrate by plenty of names: Quinine Sulphate Dihydrate (the British spelling), Chininum Sulfuricum Dihydricum, and sometimes just plain “quinine” in a casual setting. In pharmaceutical databases, it pops up as USP grade Quinine Sulfate, and product labels sometimes render it as Quininebisulfate dihydrate or simply Quinine 2H2O. Over-the-counter products in some parts of the world call it by trade names like Quino-S, Qunid, or QuinoTabs, though these vary country by country. For scientific literature or chemical suppliers, the CAS number 6119-47-7 appears most reliably, cutting confusion when dealing with similar alkaloids.
Any lab or production facility running quinine sulfate dihydrate must follow deep safety protocols. The powder irritates eyes and mucous membranes quickly; gloves, goggles, and fume hoods stop routine spills from becoming medical emergencies. Machines mixing and compressing the drug need quiet, sealed environments—not only for personnel safety but for contamination control. OSHA and international bodies require strict logs of solvent use, acid handling, and waste disposal, since slip-ups can poison not just workers but the surrounding community. Emergency showers and eyewash stations belong everywhere quinine is handled, and first responders need clear charts about antidotes and supportive care. Training isn’t just a formality—cases of accidental self-poisoning or mishandling have ended with hospitalizations, often because a tiny shortcut on standard precautions snowballed into real harm.
Malaria remains the main battleground for quinine sulfate dihydrate. Doctors reach for it in regions where Plasmodium falciparum developed resistance to newer drugs. In cases of severe malaria, especially with complications, intravenous or oral quinine can save someone teetering at death’s door. Sometimes clinics deploy it for leg cramps, but official guidelines in the U.S. and Europe call for caution—or outright retraction—given risks like cardiac arrhythmias. Beyond medicine, food and beverage companies add quinine as the sharp bitterness in tonic water, though those concentrations sit far below the therapeutic range. Modern labs use quinine in quality control and as a fluorescent marker for calibrating instruments. Borderline cases turn up in veterinary medicine, especially in tropical regions.
Retro labs and biotech giants still find value in studying quinine. Surveillance programs watch global resistance patterns, mapping outbreaks and treatment failures as parasite strains adapt to long-term quinine use. Researchers look for drug combinations that re-enable quinine against stubborn malaria, or that soften its dangerous side effects. Since quinine’s structure coincides with modern synthetic chemistry’s toolbox, organic chemists turn it into a platform for training students or exploring new reaction types. Clinical trials sometimes revive older dosing schedules to optimize safety in critical care. On the innovation side, companies tweak delivery—microencapsulation, extended-release tablets, or combination therapies with other antimalarials—so patients don’t face as many pills or severe side effects. Each trial has to battle regulatory hurdles and skeptical funders, since new drugs usually draw the most attention.
Even with lifesaving utility, quinine’s toxicity demands close attention. Large population studies in malaria hotspots document rare but catastrophic allergic reactions—quinine fever or even anaphylaxis in some cases. At therapeutic doses, patients face a well-known suite of side-effects: tinnitus, blurry vision, nausea, strange rashes, and, in unlucky cases, life-threatening arrhythmias. Higher exposures, usually from overdose or miscalculation, lead to ‘cinchonism’—clusters of neurological, gastrointestinal, and cardiac symptoms that can’t be ignored. Regulatory bodies ban quinine in over-the-counter cramp treatments because historical abuse caused fatalities. Lab rats subjected to chronic high doses show liver and kidney damage, reinforcing what clinicians observe at toxic thresholds. Monitoring individual patients with ECGs and regular bloodwork forms part of standard protocol, a habit earned through a long, checkered experience.
People tend to treat quinine as a relic, but its future holds plenty of importance. Worries about artemisinin and other frontline malaria drugs burning out in high-resistance stretches of Africa and Southeast Asia put quinine on standby as a failsafe. Synthetic biology labs hunt for ways to re-engineer bacteria to grow quinine precursors, hoping to sidestep decades-long cinchona farming cycles. Healthcare systems in vulnerable countries look to strengthen supply chains; securing affordable, stable quinine means fewer emergencies spiral out of control. Some researchers continue efforts to pare down the toxicity profile or adjust its stereo-chemistry, even if large breakthroughs prove stubborn. Food scientists work with regulatory officials to keep quinine in beverages strictly bounded—too little, and fans miss the taste; too much, and safety questions come back. Across contexts, education for healthcare providers on best practices for quinine use can head off misuse or missed diagnoses. As the world toggles between old threats and new science, quinine sulfate dihydrate remains in the conversation, ready to serve or learn something new depending on the challenges at hand.
Walk into a rural clinic in parts of sub-Saharan Africa or Southeast Asia, and you might still find Quinine Sulfate Dihydrate sitting on pharmacy shelves. This compound, derived from the bark of the cinchona tree, once stood as the world's strongest weapon against malaria. Before the discoveries of artemisinin and other newer drugs, quinine meant the difference between life and death for millions facing malaria’s fever and chills.
It would be a mistake to write off Quinine Sulfate Dihydrate as outdated. Even now, hospitals turn to quinine when modern options falter. Resistance to antimalarial drugs has spread across continents. Some strains of Plasmodium falciparum, the deadliest malaria parasite, brush off the latest treatments. In regions where people lose access to newer drugs due to cost or shortages, quinine remains one of the few lines of defense.
Most folks connect quinine with malaria, but that’s not its only medical use. For decades, doctors prescribed tablets to treat severe nighttime leg cramps, especially when other remedies failed. The United States Food and Drug Administration cracked down on this non-malarial use, mostly because of the risk of dangerous side effects, but some countries haven't banned it. The science just hasn't stacked up well enough against the risks in that arena. It’s a reminder: even medicines woven into cultural stories and folk treatments need tough scrutiny.
Ask anyone working in pharmacy or emergency care—side effects from quinine aren’t rare. Quinine carries a risk of cinchonism: a bundle of problems including ringing in the ears, headache, nausea, and blurred vision. In unlucky patients, those troubles hit hard, even at regular doses. Allergic reactions, changes in heart rhythm, and dangerous drops in blood platelets show up in rare but ugly cases. The FDA flagged these risks after seeing too many hospitalizations tied to unsupervised use.
Drinking tonic water at a bar won’t offer a medical dose—there’s hardly enough quinine left in those bottles to treat a single mosquito bite. Yet, every so often, you’ll hear someone claim a glass of tonic eases their aches or fights off chills. Most of that effect likely comes from myth and suggestion, not science.
There’s a bigger issue underneath the quinine story. Not every clinic receives steady shipments of artemisinin-based drugs. Political instability, broken supply chains, or poverty knock out access, so older drugs like quinine stay relevant. Research groups and health organizations talk plenty about bringing advances to every corner of the world. Yet, until those ambitions reach the sickest villages, doctors will keep reaching for reliable, if imperfect, drugs like quinine.
Solving these problems takes more than just chemical innovation. Countries benefit from stable health policies, better funding, coordinated distribution networks, and grassroots training that keeps clinicians up-to-date. The dream isn’t about just making the best new medicine, but making sure it travels, lands, and does the job wherever it’s needed. Until that dream becomes a reality everywhere, quinine sulfate dihydrate isn’t giving up its role just yet.
Quinine sulfate dihydrate has deep roots in the treatment of malaria. For centuries, people in tropical climates have leaned on this medication, trusting it to knock back fevers and chills from malaria. Some medications can be traced back to family stories where someone would be given a bitter-tasting pill to settle vicious bouts of illness.
A lot of folks who begin taking quinine sulfate don't expect the ride to come with digestive problems. The stomach tends to rebel. Nausea and vomiting happen fairly often. My own experience with antimalarials during time spent in rural hospitals has taught me that people fear the side effects almost as much as the disease itself. A patient would often complain of muscle cramps, a swirling headache, sometimes even ringing in the ears. These are not rare complaints. Muscle and nerve cells react in predictable but unpleasant ways. Science backs this up—muscle spasms and changes in hearing are hallmarks of quinine use, especially when doses creep higher.
The digestive tract hates bitterness. Quinine takes that to a new level, so stomach pain and even diarrhea trail in its wake. Fatigue sets in. Some feel lightheaded. One nurse told me, “I’d rather deal with the fever than the dizziness.” People notice their heart beating odd or fast, a sign to back out or cut the dose. Healthcare professionals worry about arrhythmias, which proves how quinine can mess with the beating of the heart, sometimes in dangerous ways.
Not all problems with quinine come from the gut or nervous system. Blood disorders haunt the margins. Cases of thrombocytopenia—platelets taking a nosedive—can lead to strange bruises and unexplained bleeding. During a rotation in a tropical medicine clinic, I learned to keep a close eye on gum bleeding and little spots under the skin.
Other body systems can join in the misery. Kidney injuries, sometimes quite severe, have popped up after high dosing or prolonged use. Quinine has also been linked to rare but deadly allergic reactions, where someone’s face swells or breathing becomes a struggle. Such stories keep doctors alert.
Lack of frank dialogue leaves many patients afraid or confused. A person told that “side effects may occur” doesn’t always get the gravity of what those words mean. Honest talk about risks, especially for people with existing kidney, heart, or blood issues, goes a long way. I learned long ago that giving people room to ask questions—without embarrassment—makes for better decisions and safer outcomes.
Public education remains crucial. Doctors, nurses, and pharmacists should check in regularly: any new symptoms, any unexplained bruising, dizziness, or trouble with hearing? Blood counts and heart rhythms should not be an afterthought. Research continues, but in the meantime, more careful prescribing and better follow-up go far in preventing serious harm.
Quinine sulfate dihydrate still holds a place in medicine. With respect for its risks and a solid connection between caregivers and patients, its side effects can be managed, and trust can stay intact.
Quinine sulfate dihydrate has saved countless lives by fighting off malaria. My own family’s roots in Southeast Asia come with stories of this medicine being handed out to keep fevers from becoming something worse. Modern science has refined its use, but there’s still no shortcut to knowing how and when to take it.
Doctors usually prescribe quinine sulfate dihydrate based on the person’s size, symptoms, and how severe the infection seems. I’ve watched relatives take this under close supervision in the tropics. Swallow each dose with food to avoid an upset stomach. Water helps get the pill down; don’t crush or chew it. Splitting up the daily dose helps steady the amount working in your blood. Skipping doses or taking too much can tip the scales from helpful to harmful.
Quinine works best at set intervals. Most adults follow a schedule spaced out over six to eight hours, keeping medicine at a constant level in the system. Taking it at night or with meals may ease side effects. People sometimes forget a dose. If that happens, just take it once remembered, but don’t double up. Overdosing can cause real trouble—ringing in the ears, vision changes, even dangerous heart rhythms.
Before starting quinine, always share your full health story. I’ve seen a friend end up in the ER because they didn’t mention an allergy at the clinic. Liver or kidney trouble changes how a person handles this drug. Heart issues and vision problems can get worse while taking it. Nurses and doctors need to know about blood disorders like G6PD deficiency, since quinine can cause a rare form of anemia.
Sometimes people think drug side effects are rare or overblown. In real life, I’ve watched someone get so dizzy they could barely walk after a single dose. Muscle cramps, nausea, and headaches show up often. Some people start hearing ringing or notice their vision blur, a warning sign to call a doctor fast. Quinine interacts with medicines like blood thinners, antibiotics, and even regular over-the-counter painkillers.
Skip self-diagnosis. Sudden rashes, breathing problems, fainting, or confusion call for emergency help. Though most folks just get queasy or notice mild ringing in the ears, some develop much worse reactions that demand a quick response. Talking to a healthcare provider should always come before trying to push through tough side effects.
I’ve seen doctors ask patients to check their pulse, look for new bruises, and keep a log of how they feel on treatment. Lab tests sometimes track how well organs handle the medication and make sure malaria is actually leaving the body. Staying in touch with the doctor matters just as much as taking the right pills.
In many communities, access remains an issue. Teachers, pharmacists, and local clinics need the right training to spot problems early. Community education helps people take medications safely and recognize warning signs. Families often pass down advice, but up-to-date, science-backed knowledge can make all the difference.
The old ways of trial and error no longer work in a world fighting drug resistance. Following prescribed schedules, honest communication, and health monitoring help medicines like quinine work better and stay effective. Care, vigilance, and knowledge can turn this bitter-tasting tablet into a lifeline for those who need it most.
Quinine sulfate dihydrate is best known for treating malaria, though most people these days recognize the name from tonic water. Still, as a medicine, it carries weight. There’s good reason doctors pause before writing a prescription for this drug. Quinine can cause severe side effects if it interacts with other conditions or medications someone already takes.
Heart rhythm problems make up the big red flag here. Quinine lengthens something known as the QT interval on a heart’s rhythm. People with a history of irregular heartbeat, such as those with Long QT Syndrome, could be at serious risk for dangerous arrhythmias or sudden cardiac events. Mixing quinine with other QT-prolonging drugs, like amiodarone or some antidepressants, can worsen the risk.
Patients with a known allergy to quinine or related substances (like quinidine or mefloquine) must avoid it. Allergic reactions can include skin rash, fever, and swelling, but in rare cases, breathing can stop or blood pressure drops dangerously low. There are cases where people with a history of blackwater fever, a complication of malaria, also fall into a higher-risk group for dangerous reactions.
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is more common than many realize, especially among people from African, Mediterranean, or Southeast Asian backgrounds. For these folks, quinine can spark hemolysis—the breakdown of red blood cells—leading to anemia and, at times, kidney failure. It’s easy for someone ignorant of this genetic quirk to fall seriously ill. I remember talking to a man from Ghana who was given quinine for leg cramps; he ended up in the hospital for several days after his red cell count plunged unexpectedly.
Liver and kidney diseases change how a body handles medications. Quinine sticks around longer than it should when these organs struggle. Toxicity can show up as nausea, ringing in the ears, confusion, or even blindness. Elderly people or those on dialysis face a greater chance of harm, so most doctors take extra precautions and look for safer alternatives.
Women who are pregnant face a difficult spot with malaria treatment. Malaria itself poses big risks in pregnancy, yet quinine isn't exactly gentle on a developing fetus. Some cases link quinine to birth defects or miscarriage, though malaria left untreated also leads to serious complications. The World Health Organization often supports quinine for severe cases if alternatives aren’t viable, though doctors will weigh risks and benefits for each patient. No drug is risk-free, but balancing the scale means knowing dangers on both sides.
Doctors keep tools like thorough medical history, medication reviews, and basic lab tests in their back pockets. Routine heart monitoring and blood checks can spot trouble early. In resource-rich settings, other anti-malarials like artemisinin-based drugs often take priority, given better safety records. The bottom line—medicine works best when clinicians and patients talk openly about backgrounds, symptoms, and possible changes after starting something new. Sometimes just a few extra questions saves a whole lot of heartbreak.
Growing up, stories about quinine floated around in my family. My grandfather drank tonic water because he was told it helped with leg cramps. He trusted what everyone around him was taking, but nobody talked about the risks. These days, chemists and doctors know a lot more, and quinine sulfate dihydrate has shifted from a household name to a prescription-only medication in many countries for a reason. This shift highlights an issue: people underestimate how certain drugs, especially older ones, can clash with other treatments in serious ways.
Quinine isn’t just another pill in the cabinet. It affects the electrical signals in the heart, which opens the door to trouble if it meets the wrong drug-mate. Mix quinine with a blood thinner like warfarin and you mess with clotting. Combine it with digoxin for heart problems, and your risk of dangerous heart rhythms goes way up. The heart’s natural rhythm isn’t just background noise—it’s the metronome of life, and quinine can throw it off beat.
Modern medical records back this up. A study published in the British Journal of Clinical Pharmacology found that one in ten people taking quinine landed in hospital for side effects, with many cases linked to interactions they never saw coming. It’s not always older folks at risk—anyone juggling prescriptions can get caught out.
Plenty of common medications mix poorly with quinine. Antibiotics like erythromycin, antifungals, and even antidepressants share the liver’s metabolic machinery with quinine. Since the liver can only handle so much at once, these drugs compete, nudging quinine or its companions into unsafe territory. Risk doesn't always show up as something dramatic. It could start as nausea, a racing pulse, muscle twitching, or even sudden hearing problems. Sometimes signs seem minor but point to bigger trouble brewing.
The problem isn’t just the drug but also how open people are about what they’re taking. I’ve watched people at pharmacies buy quinine sulfate for cramps, not knowing the risk with their regular heart pills. Honest conversations between patient and doctor make a world of difference. If you’re prescribed quinine, bring a full list of all medications, vitamins, and herbal supplements. Doctors can check resources like the FDA’s interaction database or the Medicines and Healthcare products Regulatory Agency’s guidelines to double-check safety.
Simple digital tools—like electronic health records with interaction warnings—reduce risk by flagging problems in real time. Pharmacies play a vital role. Pharmacists can spot issues at the counter, but only if patients share everything they’re taking.
Quinine’s story isn’t just about malaria or leg cramps—it’s about recognizing how even a trusted drug can trip people up. Modern medicine keeps records, checks pathways, and looks out for signals, but people need to speak up and ask questions. By keeping conversations open, checking combinations, and respecting drug warnings, the chance of a bad reaction goes down. Old drugs hold value but demand respect. Safety starts with good information and a willingness to share it.
| Names | |
| Preferred IUPAC name | (2R,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl (R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl](6-methoxyquinolin-4-yl)methanol sulfate dihydrate |
| Other names |
Quinimax Quinquina Fever tree bark Cinchona alkaloid sulfate Sulphate of quinine |
| Pronunciation | /ˈkwaɪniːn ˈsʌl.feɪt daɪˈhaɪdreɪt/ |
| Identifiers | |
| CAS Number | 6119-70-6 |
| Beilstein Reference | 274114 |
| ChEBI | CHEBI:8706 |
| ChEMBL | CHEMBL950 |
| ChemSpider | 21540659 |
| DrugBank | DB00468 |
| ECHA InfoCard | 03c677f6-13ae-4b5c-b72d-ca0e5d8c98e5 |
| EC Number | 200-591-6 |
| Gmelin Reference | 81896 |
| KEGG | C07296 |
| MeSH | D017348 |
| PubChem CID | 607027 |
| RTECS number | GN7380000 |
| UNII | 563GAN1RH4 |
| UN number | UN2811 |
| Properties | |
| Chemical formula | (C20H24N2O2)2·H2SO4·2H2O |
| Molar mass | 782.96 g/mol |
| Appearance | White or almost white, crystalline powder |
| Odor | Odorless |
| Density | 1.57 g/cm³ |
| Solubility in water | 1 g/800 mL |
| log P | -1.7 |
| Vapor pressure | Negligible |
| Acidity (pKa) | 8.5 |
| Basicity (pKb) | pKb: 3.95 |
| Magnetic susceptibility (χ) | -99.4e-6 cm³/mol |
| Refractive index (nD) | 1.634 |
| Dipole moment | 0 D |
| Thermochemistry | |
| Std enthalpy of formation (ΔfH⦵298) | -2074.6 kJ/mol |
| Pharmacology | |
| ATC code | N02CA02 |
| Hazards | |
| Main hazards | Harmful if swallowed. Causes serious eye irritation. May cause an allergic skin reaction. Suspected of damaging fertility or the unborn child. |
| GHS labelling | GHS07, GHS08 |
| Pictograms | GHS06,GHS08 |
| Signal word | Warning |
| Hazard statements | Hazard statements: **"H301: Toxic if swallowed. H319: Causes serious eye irritation. H335: May cause respiratory irritation. H410: Very toxic to aquatic life with long lasting effects."** |
| Precautionary statements | P264, P270, P301+P312, P501 |
| Flash point | 180 °C |
| Autoignition temperature | 410 °C |
| Lethal dose or concentration | LD50 Oral Rat 1,390 mg/kg |
| LD50 (median dose) | LD50 (median dose): Oral rat LD50 = 641 mg/kg |
| NIOSH | XP5250000 |
| PEL (Permissible) | PEL: 2 mg/m³ |
| REL (Recommended) | 0.18 mg/kg bw |
| Related compounds | |
| Related compounds |
Cinchona alkaloids Quinine Quinidine Dihydroquinine Dihydroquinidine |
